Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%

Business by 2FIRSTS.ai
Jul.22.2024
Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%
Smoore International (06969.HK) announces approval for seven e-cigarette products by RJ Reynolds Vapor Company through PMTA pathway.

On July 21, the Hong Kong-listed company Smoore International (06969.HK) announced that its customer, R.J. Reynolds Vapor Company, has been authorized through the Pre-Market Tobacco Product Application (PMTA) pathway to sell seven e-cigarette products in the United States starting July 18, 2024. The products include the Vuse Alto Power Unit and six closed, pre-filled, non-refillable Vuse Alto tobacco flavored pods: Vuse Alto Pod Golden Tobacco 5%, Vuse Alto Pod Rich Tobacco 5%, Vuse Alto Pod Golden Tobacco 2.4%, Vuse Alto Pod Rich Tobacco 2.4%, Vuse Alto Pod Golden Tobacco 1.8%, and Vuse Alto Pod Rich Tobacco 1.8%. According to Smoore International's sales records from the beginning of this year until the date of the announcement, the group has supplied these seven products to the RJR Group.

Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%


Smoore International expressed that they are greatly encouraged by their client R.J. Reynolds Vapor Company's successful premarket tobacco product application approval, believing that this will provide clearer guidance for the group to better deploy resources in the U.S. market.

Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%
Smoore International Announcement | Image source: Smoore International


As of the time of writing, Smoore International (06969) surged over 10% in early trading, reaching 9.5 Hong Kong dollars with a trading volume of 1.237 billion Hong Kong dollars.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

California and New Jersey advance bills to curb vape-waste risks tied to facility fires
California and New Jersey advance bills to curb vape-waste risks tied to facility fires
US state lawmakers and recycling groups are pursuing 2026 measures to address safety issues linked to vape waste through legislation, take-back programs and educational outreach. California’s State Assembly passed a bill to ban disposable vape pens, while New Jersey reintroduced an extended producer responsibility bill for e-cigarettes.
Feb.05 by 2FIRSTS.ai
IMiracle  Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide
IMiracle Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide
IMiracle announces significant R&D progress in 2025, with over 2,200 patent applications globally and 900 authorized patents.
Dec.18 by 2FIRSTS.ai
France drops a vaping clause from the 2026 finance bill after use of Article 49.3
France drops a vaping clause from the 2026 finance bill after use of Article 49.3
A provision in France’s 2026 finance bill intended to regulate vaping products was abandoned after Sébastien Lecornu used Article 49.3 on January 20 to commit the government’s responsibility on the “revenue” section of the state budget.
Jan.21 by 2FIRSTS.ai
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
2Firsts Outlines 2026 Global Product Trends in the New Tobacco Industry
2Firsts Outlines 2026 Global Product Trends in the New Tobacco Industry
As regulation tightens and innovation matures, competition in the new tobacco industry is shifting. In its 2026 Global Product Trends in the New Tobacco Industry report, 2Firsts examines how heated tobacco, nicotine pouches, and vape products are moving beyond feature-driven upgrades toward system-level design, where experience management, compliance structure, and engineering capability increasingly shape long-term competition.
Jan.13 by 2Firsts Perspectives
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20